MLAB 1315-Hematology Keri Brophy-Martinez Unit 26: Lipid Storage Diseases.

Slides:



Advertisements
Similar presentations
Birth Defects Resulting From Single Gene Defects.
Advertisements

Cellular Disorders. Everything that our bodies do each and every day is because of cells and their various functions If all or some of these cells lose.
A Proteopathy Disease: Gaucher’s Disease
Tay-Sachs Disease Salman Hossain Kevin Kong. History of tay-Sachs Disease The disease Tay-Sachs is named after ophthalmologist, someone who studies the.
Tay-Sachs Disease By: Madison SHUMATE.
Chapter 12 Patterns of Heredity and Human Genetics
Lethal Recessive Alleles
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
Tay-sachs Disease Yi Cheng Lisa Nguyen.
T AY S ACHS By: Varun Natraj and Kenneth Forward.
A Closer Look Ray Molzon
Week 9: Congenital WBC Problems Pelger-Huët Pelger-Huët Chediak-Higashi Chediak-Higashi Alder-Reilly Alder-Reilly Muco- polysaccharidosis Muco- polysaccharidosis.
Human Heredity and Genetic Disorders
Genetic Disorders Problem Pregnancies.
Tay-Sachs April Jones Rabun County High School July 16, 2004.
By: Aaron Nachtigall and Ethan Adcock.  Tay-Sachs was named after Warren Tay, because in 1881 he described a patient with a cherry-red spot on the retina.
TSD Tay-Sachs Disease (TSD) BY GREG DEYOUNG Introduction to Tay-Sachs Disease There are many genetic diseases in the world, some worse than others.
Tay-Sachs Disease By: Brianna Pinto, Siobhan McCarthy and Kiley McArtney.
By Ivy Poon, Diana Jackson, and Annaliese Yostpile
Stephanie Belanger January 12, 2009 AP Bio. What is Tay-Sachs Disease? An inherited autosomal recessive condition that causes progressive degeneration.
HEXA and Tay-Sachs Disease
Tay-Sachs disease S. F. Khatami Neonatologist. Ganglioside is a molecule composed of a glycosphingolipid(ceramide and oligosaccharide) with one or more.
______ _______ ______ _______ Genetic Diseases. Basic Punnett Square In this scenario, both parents are heterozygous for a particular allele A = dominant.
Clinical Data to Support Qualification: Cross-Sectional Surveys and Natural History Studies P. K. Tandon, Ph.D. Clinical Science Officer Genzyme, a Sanofi.
Complex Lipid Metabolism UNIT III: Lipid Metabolism.
Inborn Errors of Metabolism Monica Egan. Video Links Part 1: – xWwY&feature=plcphttp://
The Lysosome and lysosomal storage disorders (LSD) Part III A Clinical profile of the LSDs Serge Melançon, MD February 2009.
WHAT IS GLYCOGEN STORAGE DISEASES (GSD) ?. - GSD has 2 classes of cause : (a) Genetic (b) Acquired.
Niemann-Pick Disease Maggie W. George December 5, 2005.
Individual amino acids metabolism of clinical importance ط Overview of synthesis of some important products of amino acids : Phenylalanine, Tyrosine, Tryptophane,
Type 0 Type I Glycogen Storage Diseases Type IV Type VII Type III.
Single-gene Autosomal Disorders. Basic terminology Genotype: A A (Homozygous)A A Genotype: A B (Heterozygous)A B Single gene disorder - determined by.
Disorders and other genetic traits Bio II. Chromosomal Inheritance All but one pair of chromosomes in males and females are the same. –Autosomes - Nonsex.
Section 4: Complex Patterns of Heredity
 Could you tell?  Tay-Sachs is a mental disorder, the fatty substance called ganglioside G M2 build up in tissues and nerve cells in the brain. 
November 11, Undernutrition 61/2 m/o ex 34 WGA twins with: FTT Severe Global Developmental Delay Hypertonia Oculomotor findings Reflux.
LYSOSOMES By: Carmelitta Oakley.
MLAB Hematology Keri Brophy-Martinez
Diseases and karyotypes
Tay Sachs Disease By Dana Hienbuecher. Other Names Abbreviation: TSD Other names include GM2 gangliosidosis and Hexosaminidase A deficiency Bernard Sachs,
Tay-Sachs By : Brianna and Sydney.
G AUCHER D ISEASE Mary Jauch Persson. D IFFERENT TYPES OF THE DIEASE Type 1-childhood (most common) Enlarge liver Low blood cell level Anaemia Tiredness.
Human Genetic Disorders Every cell in the human body has 46 chromosomes except for gametes, egg sperm cells, which contain 23 or the haploid number. Human.
Lysosomal Storage Diseases. Fabry’s Disease What kind? Symptoms? Enzyme Def? What accumulates? Inheritance Pattern? Sphingolipidosis Peripheral neuropathy,
Tay Sachs Disease Linda Lu. What is Tay Sachs Disease? - A rare genetic disorder that destroys neurons in the brain and the spinal cord - Results from.
TAY-SACHS DISEASE BY ERIC WONG. TAY-SACHS DISEASE  Rare  Genetic Disorder  Destroys nerve cells (neurons)  In the brain and spinal cord  Fatal in.
Where did Tay-Sachs come from && What is it? The disease Tay-Sachs was named after Warren Tay [ ] and Bernard Sachs[ ]. Tay-Sachs is.
BATTEN DISEASE Diploma in In-service Education
By Sarah Moudy Also known as Glucocerebrosidase deficiency.
Tay-Sachs Drew Sivertsen. History Tay-Sachs is named after two physicians Warren Tay – was an ophthalmologist who was the first to discover a red dot.
1.Is NS-NPD caused by defect in a single gene or is more than one gene involved? Mutations in the NPC1, NPC2, and SMPD1 genes cause Niemann-Pick disease.
Tay-Sachs disease By Marco Rabello July/2005 NS 215 Dr.Williams.
Rachel Wells. » Warren Tay, 1881 ˃Observed symptomatic red spot in retina of eye » Bernard Sachs, 1887 ˃Described cellular changes in disease ˃Noticed.
Tay-Sachs Disease n What is it? n A degenerative neurological disorder where virtual absence of activity of a lysosomal enzyme, hexosaminidase A n Biochemistry.
LIPID STORAGE DISEASES.
Presentation On gaucher’s disease
Sphingolipids and Myelin Structure
Case of the Month 28 October 2017
MLAB Hematology Keri Brophy-Martinez
GLYCOLIPIDS ..
Genetic Disorders.
SPHINGOLIPIDS AND MYELIN STRUCTURE
Gaucher Disease (this is a hereditary disease)
SPHINGOLIPIDS AND MYELIN STRUCTURE. OUTLINES Objectives. Background. Key principles. Take home messages.
Tay Sach’s disease Kyle S.
Cellular Disorders.
Sphingolipids and Myelin Structure
Sphingolipids and Myelin Structure
Biochemistry NEUROPSYCHIATRY BLOCK
Presentation transcript:

MLAB 1315-Hematology Keri Brophy-Martinez Unit 26: Lipid Storage Diseases

LIPID (LYSOSOMAL)STORAGE DISEASES AND HISTIOCYTES These are autosomally inherited disorders known as lysosomal storage diseases because there is an accumulation of unmetabolized material in the lysosomes of various cells. They are caused by various enzyme defects (inborn errors) in lipid metabolism linked to an enzyme deficiency.

There are three main disorders: Gaucher’s Disease Enzyme deficiency: β-glucocerebrosidase Causes an accumulation of glucocerebroside in predominantly the monocyte-macrophage system Gaucher’s cell: large histiocyte (20-100Fm) with displace nucleus which contains one or more round nucleoli. Cytoplasm is faintly blue/white with characteristic “crumpled tissue paper” appearance which is probably the result of glycolipid deposition.

Gaucher’s Disease Prevalent in the Ashkenazi Jewish population (eastern European) Adult form (Type I) - most common; mild form Infantile form (Type II) - rare; death occurs by age 2 (failure to thrive); neurological involvement Juvenile form (Type III) - clinical and physical findings range between Type I and Type II

Gaucher’s Disease Treatment Enzyme replacement therapy approved in 1991 in U.S. Bone marrow transplant Supportive therapy (splenectomy)

Niemann-Pick Disease Enzyme deficiency: sphingomyelinase Causes an accumulation of unmetabolized sphingomyelin and cholesterol Niemann-Pick cell: lipid-laden giant foamy cell found in BM, tissues and other organs

Niemann-Pick Disease Increased incidence in the Jewish population Five types have been described Classic form presents with jaundice at birth, hepatosplenomegaly, enlarged lymph nodes, neurological symptoms, retarded physical and mental development. Death occurs by age 2.

Niemann-Pick Disease Treatment No current treatment is available for Type A. Type B has been successfully treated with bone marrow transplant.

Tay Sachs Disease Enzyme deficiency: hexosaminidase A Foamy lymphocytes are present but are not diagnostic.

Tay Sachs Disease Higher incidence in Ashkenazi Jewish population Severity of the disease correlates with residual enzyme activity. The buildup of unmetabolized GM2 ganglioside in the tissues has devastating effects in the central nervous system and eye. Physical and mental deterioration occur along with seizures and paralysis. Death comes by age 4.